Antinociceptive activity in Wistar rat model of chronic constriction injury-induced neuropathic pain assessed as reduction in hyperalgesia at 0.8 to 3.5 nmol after 30 mins by cold plate test
Antinociceptive activity in Wistar rat model of chronic constriction injury-induced neuropathic pain assessed as reduction in allodynia at 0.8 to 3.5 nmol after 30 mins by von Frey test
Potency index, ratio of antinociceptive activity of compound at 8 to 10 nmol, it to antinociceptive activity of morphine at 35 nmol, it in naive Wistar rat after 30 mins
Potency index, ratio of antiallodynic effect of compound to antiallodynic effect of morphine in it dosed naive Wistar rat at 0.8 to 3.5 nmol after 30 mins by cold plate test
Antinociceptive activity in Wistar rat model of chronic constriction injury-induced neuropathic pain assessed as reduction in allodynia at 3.5 nmol, it QD for 6 consecutive days by von Frey test
Antinociceptive activity in Wistar rat model of chronic constriction injury-induced neuropathic pain assessed as reduction in allodynia at 0.8 nmol, it QD for 6 consecutive days by von Frey test
Antinociceptive activity in Wistar rat model of chronic constriction injury-induced neuropathic pain assessed as reduction in hyperalgesia at 0.8 nmol, it QD for 6 consecutive days by cols plate test
Antinociceptive activity in Wistar rat model of chronic constriction injury-induced neuropathic pain assessed as reduction in hyperalgesia at 0.8 nmol, it QD for 6 consecutive days measured on day-4 and day-5 by cold plate test relative to morphine
Antinociceptive activity in Wistar rat model of chronic constriction injury-induced neuropathic pain assessed as reduction in hyperalgesia at 3.5 nmol dosed on day7 after tolerance development with compound13 dosed at 1 nmol, it QD for 6 days by cold plate test
Antinociceptive activity in Wistar rat model of chronic constriction injury-induced neuropathic pain assessed as reduction in hyperalgesia at 0.8 nmol dosed on day7 after tolerance development with morphine dosed at 3.5 nmol, it QD for 6 days by cold plate test
Antinociceptive activity in Wistar rat model of chronic constriction injury-induced neuropathic pain assessed as reduction in allodynia at 0.8 nmol dosed on day7 after tolerance development with morphine dosed at 3.5 nmol, it QD for 6 days by von Frey test